Document is current
Any future updates will be listed below
-
Authors
Dosoky, Noura S.
Chen, Zhongyi
Guo, Yan
McMillan, Clara
Flynn, C. Robb
Davies, Sean S. https://orcid.org/0000-0001-9879-8062
-
Funding
Funding for this research was provided by:
National Center for Complementary and Integrative Health (AT007830)
National Institute of Diabetes and Digestive and Kidney Diseases (DK059637)
National Cancer Institute (CA68485)
National Eye Institute (EY08126)
Foundation for the National Institutes of Health (RR030956)
- License Information
-
More Information
Article History
Received: 27 February 2019
Revised: 28 May 2019
Accepted: 30 May 2019
First Online: 15 June 2019
Compliance with ethical standards
:
: Author 2 (ZC) and Author 6 (SSD) have a patent pending for the use of engineered bacteria expressing NAPE or NAE for treating obesity. Authors 1, 3, 4, and 5 declare that they have no conflict of interest.
: All applicable international, national, and institutional guidelines for care and use of animals were followed. This article does not contain any studies with human participants performed by any of the authors.
: The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
